Research

Hormonal

Current clinical-metabolomic biomarkers (including BCAA and lipid profiles) cannot predict individual changes in insulin sensitivity following lifestyle interventions, despite their ability to correlate with baseline insulin levels.

Do not rely on current commercial metabolomic tests (like BCAA or lipid profiling) to predict whether you will lose weight or improve insulin sensitivity through exercise or diet. These tests may tell you your current risk level, but they cannot tell you if a specific intervention will work for you. Monitor actual physiological changes using high-sensitivity insulin assays if possible.

GoodRefutesHIGH confidence
Thus, we demonstrate that the choice of insulin assay is critical when quantifying the influence of life-style on fasting insulin, while none of the clinical-metabolomic biomarkers, validated in cross-sectional data, are suitable for monitoring longitudinally changes in IR status.
Rebecca S. Brogan et al. · medRxiv · 2024

Source

Biomarkers of insulin resistance and their performance as predictors of treatment response in overweight adults

Rebecca S. Brogan et al. · medRxiv · 2024

DOI 10.1101/2024.10.06.24314962

preprint · n=444Cited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →